BR112014032456A2 - métodos in vitro, composição farmacêutica, kit para realização do método e método para melhorar o efeito de tratamento - Google Patents
métodos in vitro, composição farmacêutica, kit para realização do método e método para melhorar o efeito de tratamentoInfo
- Publication number
- BR112014032456A2 BR112014032456A2 BR112014032456A BR112014032456A BR112014032456A2 BR 112014032456 A2 BR112014032456 A2 BR 112014032456A2 BR 112014032456 A BR112014032456 A BR 112014032456A BR 112014032456 A BR112014032456 A BR 112014032456A BR 112014032456 A2 BR112014032456 A2 BR 112014032456A2
- Authority
- BR
- Brazil
- Prior art keywords
- improving
- pharmaceutical composition
- treatment effect
- vitro methods
- kit
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57415—Specifically defined cancers of breast
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/475—Assays involving growth factors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Oncology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Hospice & Palliative Care (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261664612P | 2012-06-26 | 2012-06-26 | |
US201261697667P | 2012-09-06 | 2012-09-06 | |
PCT/EP2013/063094 WO2014001232A1 (en) | 2012-06-26 | 2013-06-24 | Blood plasma biomarkers for bevacizumab combination therapies for treatment of breast cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112014032456A2 true BR112014032456A2 (pt) | 2017-06-27 |
Family
ID=48672633
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112014032456A BR112014032456A2 (pt) | 2012-06-26 | 2013-06-24 | métodos in vitro, composição farmacêutica, kit para realização do método e método para melhorar o efeito de tratamento |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP2864788A1 (pt) |
JP (1) | JP2015522815A (pt) |
KR (1) | KR20150024342A (pt) |
CN (1) | CN104364655A (pt) |
BR (1) | BR112014032456A2 (pt) |
CA (1) | CA2871385A1 (pt) |
HK (1) | HK1202334A1 (pt) |
MX (1) | MX2014014821A (pt) |
RU (1) | RU2015102026A (pt) |
WO (1) | WO2014001232A1 (pt) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11674182B2 (en) | 2017-03-08 | 2023-06-13 | Industry-University Cooperation Foundation Hanyang University | Biomarker for HER2-positive cancer and anti-HER2 therapy and applications thereof |
KR102028703B1 (ko) * | 2017-11-21 | 2019-10-04 | 한양대학교 산학협력단 | 유방암의 진단 및 치료를 위한 바이오 마커 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4933294A (en) | 1984-01-30 | 1990-06-12 | Icrf Patents Limited | Method of detecting truncated epidermal growth factor receptors |
US5401638A (en) | 1986-06-04 | 1995-03-28 | Oncogene Science, Inc. | Detection and quantification of neu related proteins in the biological fluids of humans |
IL85035A0 (en) | 1987-01-08 | 1988-06-30 | Int Genetic Eng | Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same |
JP3040121B2 (ja) | 1988-01-12 | 2000-05-08 | ジェネンテク,インコーポレイテッド | 増殖因子レセプターの機能を阻害することにより腫瘍細胞を処置する方法 |
US5081034A (en) | 1988-11-14 | 1992-01-14 | Brigham & Women's Hospital | Cloned genes which encode elam-1 |
DE68926248T2 (de) | 1989-09-29 | 1996-12-19 | Oncogene Science Inc | p100 "neu" menschlisches Protein and Verwendung dieses Proteins zum Nachweis von preneoplasmatischen- oder neoplasmatischen beim Menschen |
JP4124480B2 (ja) | 1991-06-14 | 2008-07-23 | ジェネンテック・インコーポレーテッド | 免疫グロブリン変異体 |
US5635388A (en) | 1994-04-04 | 1997-06-03 | Genentech, Inc. | Agonist antibodies against the flk2/flt3 receptor and uses thereof |
US5994071A (en) | 1997-04-04 | 1999-11-30 | Albany Medical College | Assessment of prostate cancer |
US6884879B1 (en) | 1997-04-07 | 2005-04-26 | Genentech, Inc. | Anti-VEGF antibodies |
DE19806989A1 (de) | 1998-02-19 | 1999-08-26 | Roche Diagnostics Gmbh | Erzeugung räumlich scharf begrenzter Festphasen für Bindungsassays |
US6833349B2 (en) * | 1999-06-08 | 2004-12-21 | Regeneron Pharmaceuticals, Inc. | Methods of treating inflammatory skin diseases |
US20050106667A1 (en) | 2003-08-01 | 2005-05-19 | Genentech, Inc | Binding polypeptides with restricted diversity sequences |
DE102004029909A1 (de) | 2004-06-21 | 2006-01-19 | Roche Diagnostics Gmbh | Verfahren und Vorrichtung zur Herstellung von bindungsfähigen Reagenzträgern |
JP2011502513A (ja) * | 2007-11-09 | 2011-01-27 | ジェネンテック, インコーポレイテッド | 癌患者における診断用途のための方法および組成物 |
CA2717489A1 (en) * | 2008-02-29 | 2009-09-24 | Shinshu University | Kit for detecting cancer cells metastasizing into sentinel lymph node |
BRPI0812682A2 (pt) | 2008-06-16 | 2010-06-22 | Genentech Inc | tratamento de cáncer de mama metastático |
US20100029491A1 (en) * | 2008-07-11 | 2010-02-04 | Maike Schmidt | Methods and compositions for diagnostic use for tumor treatment |
CA2766403A1 (en) * | 2009-07-13 | 2011-01-20 | Genentech, Inc. | Diagnostic methods and compositions for treatment of cancer |
JP2013501526A (ja) * | 2009-08-14 | 2013-01-17 | ジェネンテック, インコーポレイテッド | Vegfアンタゴニストに対する患者の応答をモニターするための生物学的マーカー |
MX2012008153A (es) * | 2010-01-12 | 2012-11-06 | Nestec Sa | Metodos para predecir la respuesta a terapia de cancer de mama triple negativo. |
AU2011281702A1 (en) * | 2010-07-19 | 2013-01-31 | F. Hoffmann-La Roche Ag | Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy |
-
2013
- 2013-06-24 WO PCT/EP2013/063094 patent/WO2014001232A1/en active Application Filing
- 2013-06-24 CA CA2871385A patent/CA2871385A1/en not_active Abandoned
- 2013-06-24 JP JP2015519012A patent/JP2015522815A/ja active Pending
- 2013-06-24 MX MX2014014821A patent/MX2014014821A/es unknown
- 2013-06-24 CN CN201380030336.6A patent/CN104364655A/zh active Pending
- 2013-06-24 EP EP13730890.4A patent/EP2864788A1/en not_active Withdrawn
- 2013-06-24 BR BR112014032456A patent/BR112014032456A2/pt not_active IP Right Cessation
- 2013-06-24 KR KR20147035874A patent/KR20150024342A/ko not_active Application Discontinuation
- 2013-06-24 RU RU2015102026A patent/RU2015102026A/ru not_active Application Discontinuation
-
2015
- 2015-03-19 HK HK15102817.0A patent/HK1202334A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CN104364655A (zh) | 2015-02-18 |
CA2871385A1 (en) | 2014-01-03 |
WO2014001232A1 (en) | 2014-01-03 |
HK1202334A1 (en) | 2015-09-25 |
MX2014014821A (es) | 2015-02-12 |
JP2015522815A (ja) | 2015-08-06 |
EP2864788A1 (en) | 2015-04-29 |
KR20150024342A (ko) | 2015-03-06 |
RU2015102026A (ru) | 2016-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1215378A1 (zh) | 藥物組合物、治療方法及其用途 | |
HRP20181364T8 (hr) | Aminotriazolopiridin, namijenjen upotrebi u liječenju upale, te njegovi farmacetski pripravci | |
PL2672966T3 (pl) | Kompozycja farmaceutyczna, sposoby leczenia i jej zastosowania | |
HK1203566A1 (en) | Methods and compositions for treating huntingtons disease | |
BR112014023937A2 (pt) | composição farmacêutica, agente farmacêutico de combinação e método de tratamento | |
IL236892B (en) | A combination of an immunoconjugate and an antibody for use in medical treatment, a pharmaceutical preparation and a kit containing it | |
BR112014002621A2 (pt) | anticorpo, composição farmacêutica, combinação farmacêutica, dna e método de tratamento | |
PT2729151T (pt) | Composição farmacêutica, métodos de tratamento e suas utilizações | |
CO6791606A2 (es) | Composiciones y métodos para el tratamiento en aplicaciones clínicas de amplio espectro, no diferenciadas o combinadas | |
BR112014019750A2 (pt) | composto, composlção farmacêutlca, método para aumentar a lnclusão de éxon 7 de smn2 em mrna, método para aumentar a quantidade de proteína smn e método para tratar sma em um indivíduo humano em necessidade | |
BR112013033811A2 (pt) | composição, método de preparação da composição, e, composto | |
IL225597A0 (en) | Pharmaceutical preparation, methods of treatment and its uses | |
HK1224184A1 (zh) | 用於治療炎性疾病的化合物、藥物組合物和方法 | |
BR112014004192A2 (pt) | composição de tratamento de sementes, e, método de tratamento de sementes | |
BR112013033078A2 (pt) | partícula, composição farmacêutica, conjunto para o tratamento do câncer e método para o tratamento do câncer em um paciente | |
BR112013034055A2 (pt) | alcaftadina para uso no tratamento de urticária | |
BR112014031512A2 (pt) | composição cosmética e método para o tratamento cosmético. | |
BR112014022694A2 (pt) | novos métodos e composições para o tratamento de doença | |
BR112015008798A2 (pt) | método para o tratamento de plantas e uso | |
BR112013028890A2 (pt) | composições e métodos para o tratamento de câncer | |
BR112014003556A2 (pt) | método de tratamento de vírus, e, composição farmacêutica | |
EP2724725A4 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF SCALES ON THE SKIN AND METHOD FOR THE TREATMENT OF SCALES ON THE SKIN THEREWITH | |
BR112014032456A2 (pt) | métodos in vitro, composição farmacêutica, kit para realização do método e método para melhorar o efeito de tratamento | |
BR112013033475A2 (pt) | composição farmacêutica para tratamento, prevenção ou melhora da ejaculação precoce e método para tratamento, prevenção ou melhora da ejaculação precoce | |
BR112015013877A2 (pt) | método, e, composição |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law | ||
B06F | Objections, documents and/or translations needed after an examination request according art. 34 industrial property law | ||
B06F | Objections, documents and/or translations needed after an examination request according art. 34 industrial property law | ||
B06I | Technical and formal requirements: publication cancelled |
Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2462 DE 13/03/2018 POR TER SIDO INDEVIDA. |
|
B08F | Application fees: dismissal - article 86 of industrial property law |
Free format text: REFERENTE A 6A ANUIDADE. |
|
B08K | Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87) |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2519 DE 16-04-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |